Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

被引：45
|
作者：
Risiglione, Pierpaolo [1 ]
Zinghirino, Federica [1 ]
Di Rosa, Maria Carmela [1 ]
Magri, Andrea [2 ,3 ]
Messina, Angela [2 ,3 ]
机构：
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[2] Univ Catania, Dept Biol Geol & Environm Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[3] WeMitoBiotech SRL, C So Italia 172, I-95125 Catania, Italy
来源：
BIOMOLECULES | 2021年 / 11卷 / 05期
关键词：
Alpha-Synuclein; mitochondria; VDAC; Parkinson's disease; mitochondrial dysfunction; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; HEXOKINASE-I; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; SUPEROXIDE-PRODUCTION; OLIGOMERS INTERACT;
D O I：
10.3390/biom11050718
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alpha-Synuclein (alpha Syn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including alpha Syn. This review analyzes the main aspects of alpha Syn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.
引用
收藏
页数：19
相关论文
共 50 条
  • [41] α-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Mullin, Stephen
    Schapira, Anthony
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 587 - 597
  • [42] α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Stephen Mullin
    Anthony Schapira
    Molecular Neurobiology, 2013, 47 : 587 - 597
  • [43] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [44] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [45] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [46] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [47] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    NATURE, 1997, 388 (6639) : 232 - 233
  • [48] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
  • [49] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [50] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
    Shannon, Daniel
    Bugada, John-Paul
    Collins, Ethan
    Fischer, Ellie
    Hellard, Delaney
    Hoffman, Trevor
    Kellogg, Nick
    Peters, Kyle
    Poetker, Garret
    Young, Logan
    Diao, JiaJie
    FASEB JOURNAL, 2020, 34
12345